BioLineRx Ltd (BLRX) Free cash flow 2016–2025
BioLineRx Ltd (BLRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.1MFY2025 · since FY2016: -$14.6M → -$8.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.1M | +81.6% |
| FY2024 | -$43.9M | -93.3% |
| FY2023 | -$22.7M | +13.8% |
| FY2022 | -$26.4M | -11.4% |
| FY2021 | -$23.7M | -2.0% |
| FY2020 | -$23.2M | -2.1% |
| FY2019 | -$22.7M | +6.7% |
| FY2018 | -$24.4M | -16.7% |
| FY2017 | -$20.9M | -43.4% |
| FY2016 | -$14.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice